These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 4268929)
1. Hypersecretion of growth hormone in an acromegalic of 25 years' duration. Teo SK; Cheah JS Med J Malaysia; 1973 Mar; 27(3):220-2. PubMed ID: 4268929 [No Abstract] [Full Text] [Related]
2. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly]. Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102 [No Abstract] [Full Text] [Related]
3. In vitro release of monkey pituitary growth hormone by acromegalic plasma. Hagen TC; Lawrence AM; Kirsteins L J Clin Endocrinol Metab; 1971 Sep; 33(3):448-51. PubMed ID: 4998974 [No Abstract] [Full Text] [Related]
4. [Radioimmunoassay evaluation of somatotropin in acromegalics. Effect of tolbutamide]. Scornavachi JC; Comini E; Altschuler N; Andrada JA Medicina (B Aires); 1971; 31(4):317-22. PubMed ID: 5129005 [No Abstract] [Full Text] [Related]
5. Human growth hormone. Characterization of plasma and pituitary components and application of a new radioreceptor assay. Gorden P; Lesniak MA; Hendricks CM; Roth J; McGuffin W; Gavin JR Isr J Med Sci; 1974 Oct; 10(10):1239-46. PubMed ID: 4140167 [No Abstract] [Full Text] [Related]
6. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients. van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464 [TBL] [Abstract][Full Text] [Related]
7. [Significance of basal blood somatotropin in man during normal and pathological states]. Giordano G; Marugo M; Minuto F; Barreca T Arch Maragliano Patol Clin; 1972; 28(1):73-99. PubMed ID: 4679290 [No Abstract] [Full Text] [Related]
13. [Permanent and non-suppressable somatotropic hypersecretion in acromegaly]. Strauch G; Modigliani E; Bricaire H Presse Med (1893); 1970 Jan; 78(4):167-70. PubMed ID: 4907364 [No Abstract] [Full Text] [Related]
14. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Dohán O; Góth M; Szabolcs I; Kovács L; Kovács Z; Szilágyi G Orv Hetil; 1993 Oct; 134(42):2301-3. PubMed ID: 8233444 [TBL] [Abstract][Full Text] [Related]
15. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects. Molinatti GM; Camanni F; Massara F; Isaia GC Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217 [No Abstract] [Full Text] [Related]
17. Growth and renal control of plasma phosphate. Corvilain J; Abramow M J Clin Endocrinol Metab; 1972 Mar; 34(3):452-9. PubMed ID: 5011249 [No Abstract] [Full Text] [Related]
18. Plasma growth hormone studies in normal individuals and acromegalic patients. Garcia JF; Linfoot JA; Manougian E; Born JL; Lawrence JH J Clin Endocrinol Metab; 1967 Oct; 27(10):1395-402. PubMed ID: 6057820 [No Abstract] [Full Text] [Related]
19. [Level of serum gonadotropin in 50 cases of acromegaly]. Franchimont P Presse Med (1893); 1968 Jul; 76(29):1475-8. PubMed ID: 4299557 [No Abstract] [Full Text] [Related]
20. [Acromegaly. I. Diagnostic use of radioimmunological determination of the somatotropic hormone]. Marek J; Srámková J; Bleha O; Engelberth O Cas Lek Cesk; 1973; 112(24):745-50. PubMed ID: 4714502 [No Abstract] [Full Text] [Related] [Next] [New Search]